Circulating markers for prognosis of hepatocellular carcinoma

by Wong, K.-F., Xu, Z., Chen, J., Lee, N.P., Luk, J.M.
Published 2014

HNF1α and CDX2 transcriptional factors bind to cadherin-17 (CDH17) gene promoter and modulate its expression in hepatocellular carcinoma

by Zhu, R., Wong, K.-F., Lee, N.P.Y., Lee, K.-F., Luk, J.M.C.
Published 2014

Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma

by Lee, N.P., Poon, R.T.P., Shek, F.H., Ng, I.O.L., Luk, J.M.
Published 2016

MiR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma

by Liu, A.M., Xu, Z., Shek, F.H., Wong, K.-F., Lee, N.P., Poon, R.T., Chen, J., Luk, J.M.
Published 2014

Proteomics of hepatocellular carcinoma: Serum vimentin as a surrogate marker for small tumors (≤2 cm)

by Sun, S., Poon, R.T.P., Lee, N.P., Yeung, C., Chan, K.L., Ng, I.O.L., Day, P.J.R., Luk, J.M.
Published 2016

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: A retrospective cohort study

by Liu, A.M., Yao, T.-J., Wang, W., Wong, K.-F., Lee, N.P., Fan, S.T., Poon, R.T.P., Gao, C., Luk, J.M.
Published 2014

Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma

by Wang Y., Shek F.H., Wong K.F., Liu L.X., Zhang X.Q., Yuan Y., Khin E., Hu M.-Y., Wang J.H., Poon R.T.P., Hong W., Lee N.P., Luk J.M.
Published 2019

Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma

by Ivanovska, I., Zhang, C., Liu, A.M., Wong, K.F., Lee, N.P., Lewis, P., Philippar, U., Bansal, D., Buser, C., Scott, M., Mao, M., Poon, R.T.P., Fan, S.T., Cleary, M.A., Luk, J.M., Dai, H.
Published 2014

Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker

by Chen, L., Ho, D.W.Y., Lee, N.P.Y., Sun, S., Lam, B., Wong, K.-F., Yi, X., Lau, G.K., Ng, E.W.Y., Poon, T.C.W., Lai, P.B.S., Cai, Z., Peng, J., Leng, X., Poon, R.T.P., Luk, J.M.
Published 2014

MicroRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma

by Burchard, J., Zhang, C., Liu, A.M., Poon, R.T.P., Lee, N.P.Y., Wong, K.-F., Sham, P.C., Lam, B.Y., Ferguson, M.D., Tokiwa, G., Smith, R., Leeson, B., Beard, R., Lamb, J.R., Lim, L., Mao, M., Dai, H., Luk, J.M.
Published 2014

DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival

by Luk, J.M., Burchard, J., Zhang, C., Liu, A.M., Wong, K.F., Shek, F.H., Lee, N.P., Fan, S.T., Poon, R.T., Ivanovska, I., Philippar, U., Cleary, M.A., Buser, C.A., Shaw, P.M., Lee, C.-N., Tenen, D.G., Dai, H., Mao, M.
Published 2014

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

by Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N.P., Lee, W.H., Ariyaratne, P.N., Tennakoon, C., Mulawadi, F.H., Wong, K.F., Liu, A.M., Poon, R.T., Fan, S.T., Chan, K.L., Gong, Z., Hu, Y., Lin, Z., Wang, G., Zhang, Q., Barber, T.D., Chou, W.-C., Aggarwal, A., Hao, K., Zhou, W., Zhang, C., Hardwick, J., Buser, C., Xu, J., Kan, Z., Dai, H., Mao, M., Reinhard, C., Wang, J., Luk, J.M.
Published 2013

Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma

by Kan, Z., Zheng, H., Liu, X., Li, S., Barber, T.D., Gong, Z., Gao, H., Hao, K., Willard, M.D., Xu, J., Hauptschein, R., Rejto, P.A., Fernandez, J., Wang, G., Zhang, Q., Wang, B., Chen, R., Wang, J., Lee, N.P., Zhou, W., Lin, Z., Peng, Z., Yi, K., Chen, S., Li, L., Fan, X., Yang, J., Ye, R., Ju, J., Wang, K., Estrella, H., Deng, S., Wei, P., Qiu, M., Wulur, I.H., Liu, J., Ehsani, M.E., Zhang, C., Loboda, A., Sung, W.K., Aggarwal, A., Poon, R.T., Fan, S.T., Wang, J., Hardwick, J., Reinhard, C., Dai, H., Li, Y., Luk, J.M., Mao, M.
Published 2014